CJASN
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published ahead of print on July 16, 2008
Clin J Am Soc Nephrol 3: 1339-1349, 2008
© 2008 American Society of Nephrology
doi: 10.2215/CJN.01600408

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
CJN.01600408v1
3/5/1339    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Audard, V.
Right arrow Articles by Ronco, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Audard, V.
Right arrow Articles by Ronco, P.

Clinical Nephrology

Renal Lesions Associated with IgM-Secreting Monoclonal Proliferations: Revisiting the Disease Spectrum

Vincent Audard*, Benoit Georges{dagger}, Philippe Vanhille{ddagger}, Cécile Toly§,||, Benjamin Deroure, Fadi Fakhouri**, René Cuvelier{dagger}{dagger}, Xavier Belenfant{ddagger}{ddagger}, Brigitte Surin§§, Pierre Aucouturier||, Béatrice Mougenot||||, and Pierre Ronco§§,¶¶

* Nephrology and Renal Transplantation Department, Hôpital Henri Mondor, Assistance Publique - Hôpitaux de Paris (APHP), Institut Francilien de recherche en Néphrologie et Transplantation, INSERM U 841, University of Paris 12, Créteil, France; {dagger} Nephrology Department, Centre hospitalier de Namur, Namur, Belgium; {ddagger} Nephrology Department, Hôpital de Valenciennes, Valenciennes, France; § Hematology and Immunology Department, Hôpital Tenon, APHP, Université Pierre et Marie Curie (UPMC) University of Paris 06, Paris, France; || Hôpital Saint Antoine, INSERM, UMR S 712, APHP, UPMC University of Paris 06, Paris, France; Nephrology and Renal Transplantation Department, Hôpital Kremlin Bicêtre, APHP, Le Kremlin Bicêtre, France; ** Nephrology Department, Hôpital Necker, APHP, University of Paris 05, Paris, France; {dagger}{dagger} Nephrology Department, Centre hospitalier de Mouscron, Mouscron, Belgium; {ddagger}{ddagger} Nephrology Department, Hôpital de Montreuil, Montreuil, France; §§ INSERM UMR S 702; UPMC University of Paris 06, Paris, France; and |||| Pathology Department and ¶¶ Nephrology Department, Hôpital Tenon, APHP, Paris, France

Correspondence: Dr. Vincent Audard, Henri Mondor Hospital, Nephrology Department, 51 Avenue du Maréchal de Lattre de Tassigny, 94000 Creteil, France; Phone: 33-1-49-81-24-53; Fax: 33-1-49-81-24-52; E-mail: vincent.audard{at}hmn.aphp.fr; or Dr. Pierre Ronco, Tenon Hospital, Nephrology Department, 4 rue de la Chine, 75020 Paris; Phone: 33-1-56-01-66-39; Fax: 33-1-56-01-69-99; E-mail: pierre.ronco{at}tnn.aphp.fr

Background and objectives: Since the first description of pathology of the kidney in Waldenström disease in 1970, there have been few reports on kidney complications of IgM-secreting monoclonal proliferations. Here, we aimed to revisit the spectrum of renal lesions occurring in patients with a serum monoclonal IgM.

Design, setting, participants, & measurements: Fourteen patients with a circulating monoclonal IgM and a kidney disease related to B cell proliferation were identified retrospectively. Demographic, clinical, and laboratory data were assessed for each patient at the time of kidney biopsy.

Results: Seven patients had a nephrotic syndrome. Patients without nephrotic syndrome all had impaired renal function. Mean serum creatinine was 238 µmol/L. For five patients, the diagnosis of monoclonal IgM preceded the kidney disease by 28.8 mo (range 12 to 60). Seven patients had Waldenström disease, two had a small B cell non-Hodgkin lymphoma, one had an IgM-excreting multiple myeloma, one had a marginal zone B cell lymphoma, and three had an IgM-related disorder. Renal lesions included (1) intracapillary monoclonal deposits disease with granular, electron-dense IgM thrombi occluding capillary lumens (5); (2) atypical membranoproliferative glomerulonephritis (3); (3) {lambda} light chain amyloidosis (2) associated with µ deposits in one patient; (4) acute tubular necrosis (1); and (5) CD20+ lymphomatous infiltration (3). Remission of the nephrotic syndrome was attained in three of seven patients, and renal function improved after chemotherapy.

Conclusions: Although renal complications of IgM proliferations are rare, a wide spectrum of kidney lesions is observed, without correlation with the type of hematologic disorder.




This article has been cited by other articles:


Home page
BMJ Case ReportsHome page
M. Prasad, A. Maitra, N. Sethiya, V K Bharadwaj, V. Chowdhury, J. Valecha, and R. Biswas
Acute renal failure followed by low back ache
BMJ Case Reports, November 3, 2009; 2009(nov03_1): bcr0320091726 - bcr0320091726.
[Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 by the American Society of Nephrology.